BILL ANALYSIS                                                                                                                                                                                                    



                                                                       


           ------------------------------------------------------------ 
          |SENATE RULES COMMITTEE            |                   SB 545|
          |Office of Senate Floor Analyses   |                         |
          |1020 N Street, Suite 524          |                         |
          |(916) 445-6614         Fax: (916) |                         |
          |327-4478                          |                         |
           ------------------------------------------------------------ 
           
                                         
                              UNFINISHED BUSINESS


          Bill No:  SB 545
          Author:   Speier (D), et al
          Amended:  9/3/03
          Vote:     21

           
           SENATE BUSINESS & PROFESSIONS COMMITTEE  :  4-1, 4/7/03
          AYES:  Figueroa, Cedillo, Machado, Vincent
          NOES:  Aanestad
          NO VOTE RECORDED:  Brulte, Murray

           SENATE APPROPRIATIONS COMMITTEE  :  7-5, 6/4/03
          AYES:  Alpert, Burton, Escutia, Karnette, Machado, Murray,  
            Speier
          NOES:  Battin, Aanestad, Ashburn, Johnson, Poochigian
          NO VOTE RECORDED:  Bowen

           SENATE FLOOR  :  21-15, 6/5/03
          AYES:  Alarcon, Alpert, Burton, Cedillo, Chesbro, Dunn,  
            Escutia, Figueroa, Karnette, Kuehl, Machado, Murray,  
            Ortiz, Perata, Romero, Scott, Sher, Soto, Speier,  
            Torlakson, Vasconcellos
          NOES:  Aanestad, Ackerman, Ashburn, Battin, Brulte, Denham,  
            Hollingsworth, Johnson, Knight, Margett, McClintock,  
            McPherson, Morrow, Oller, Poochigian
          NO VOTE RECORDED:  Bowen, Ducheny, Florez, Vincent

           ASSEMBLY FLOOR  :  48-29, 9/5/03 - See last page for vote


           SUBJECT  :    Emergency contraception drug therapy

           SOURCE  :     The American College of Obstetricians and  
          Gynocologists
                                                           CONTINUED





                                                                SB 545
                                                                Page  
          2



           DIGEST  :    This bill caps the administrative fee charged to  
          patients for emergency contraception at $10 for prescribers  
          of telephone or electronic prescriptions and for  
          pharmacists.

           Assembly Amendments

           1.Require the pharmacist, prior to furnishing an emergency  
            contraception, to complete a training program consisting  
            of at least one hour of approved continuing education on  
            emergency contraception drug therapy.

          2.Provide that no more than a $10 administrative fee may be  
            charged for prescribers of telephone or electronic  
            prescriptions and for pharmacists.

          3.Prohibit a pharmacist from requiring a patient to provide  
            individually identifiable medical information except as  
            specified.

          4.Require a pharmacist, upon request, to disclose the total  
            retail drug price for emergency contraception drug  
            therapy.

          5.Incorporate additional changes to Section 4052 of the  
            Business and Professions Code proposed by SB 490 (Alpert)  
            that becomes operative only if SB 490 and this bill are  
            both enacted and become effective on or before January 1,  
            2004, and this bill is enacted last.  

          ANALYSIS  :    

          This bill:

          1.Prohibits an individual authorized to prescribe emergency  
            contraception who issues a prescription or order for  
            emergency contraception (EC) drug therapy as a result of  
            a patient contract by telephone or electronic means from  
            charging an administrative fee or fees totaling more than  
            $10 for EC services.

          2.Prohibits a pharmacist, pharmacist's employer, or  







                                                                SB 545
                                                                Page  
          3

            pharmacist's agent from directly charging a separate  
            consultation fee to a patient for emergency contraception  
            drug therapy services that is initiated, but permits a  
            pharmacists to charge an administrative fee of up to $10  
            above the retail cost 

          3.Repeals a requirement that a pharmacist, prior to  
            furnishing EC, have completed a training program on EC,  
            which includes, but is not limited to, conduct of  
            sensitive communications, quality assurance, referral to  
            additional services, and documentation, and, instead,  
            requires a pharmacist, prior to furnishing EC, to  
            complete a training program on EC consisting of at least  
            one hour of approved continuing education on EC drug  
            therapy.

          4.Prohibits a pharmacist from requiring a patient to  
            provide specified individually identifiable medication  
            information beyond what is contained in a specified  
            regulation before initiating EC.

           Comments

           Emergency contraception therapy is a drug regimen that  
          reduces the change of pregnancy significantly if  
          administered within 72 hours of unprotected intercourse  
          (sometimes referred to as "morning after pills").  SB 1169  
          (Alpert), Chapter 900, Statutes of 2001, authorized a  
          pharmacist to initiate EC drug therapy in accordance with  
          standardized protocols developed by the pharmacist and an  
          authorized prescriber acting within his or her scope of  
          practice.  SB 1169 requires a pharmacist, prior to  
          initiating emergency contraception drug therapy, to  
          complete a training program on emergency contraception that  
          covers the conduct of sensitive communications, quality  
          assurance, referral to additional services, and  
          documentation.  The pharmacist must also provide each  
          recipient of the emergency contraception   services with a  
          standardized fact sheet, developed by the Pharmacy Board,  
          that includes the indications for the drug, the appropriate  
          method for using the drug, the need for medical follow-up,  
          and other information.  Pharmacists must also sign  
          "protocol" agreements with individual physicians so that  
          the pharmacist can dispense the drugs as directed.







                                                                SB 545
                                                                Page  
          4


          Current law does not limit the amount a pharmacist or  
          prescriber can charge a private-pay patient for EC, or the  
          amount of the consulation/dispensing fee.  This bill does  
          not cap the amount that can be charged for EC (e.g., the  
          bills), but caps the administrative fee at $10.

           FISCAL EFFECT  :    Appropriation:  No   Fiscal Com.:  Yes    
          Local:  Yes

          According to the Assembly Appropriations Committee, minor  
          and absorbable costs to the Medical Board and the Pharmacy  
          Board.  The Medical Board operating costs are funded from  
          physician licensing fees deposited in the Medical Board  
          Contingency Fund, and Pharmacy Board operating costs are  
          funded from pharmacist licensing fees deposited in the  
          Pharmacy Board Contingent Fund.

           SUPPORT :   (Verified  9/3/03)

          American College of Obstetricians and Gynecologists  
          (source)
          American Association of University Women
          American Civil Liberties Union
          California Abortion Rights Action League
          California Commission on the Status of Women
          California Medical Association
          California National Organization for Women
          California Nurses Association
          California Nurses Midwives Association
          California Women Lawyers
          Planned Parenthood Affiliates of California
          Planned Parenthood Golden Gate
          Santa Barbara Women's Political Committee
          The American Nurses Association of California

           OPPOSITION  :    (Verified  9/3/03)

          California Catholic Conference
          California Grocers Association
          California Retailers Association
          California Society of Health-System Pharmacists
          Rite Aid








                                                                SB 545
                                                                Page  
          5

           ARGUMENTS IN SUPPORT  :    In their letters of support, many  
          proponents of this bill argue that the current system of  
          dispensing EC drug therapy is impeding public access to a  
          critical and time sensitive emergency drug therapy.  They  
          state that some pharmacists are charging a consultation fee  
          that in some cases is greater than the actual cost of the  
          drug.

          In their letter of support, the California Medical  
          Association states that EC drug therapy is safe and  
          recommends that it should be made available to consumes  
          over-the-counter.  The California National Organization for  
          Women (CANOW) also states that EC drug therapy is safe.   
          CANOW maintains that when EC drug therapy is dispensed to a  
          patient, the pharmacist is required to provide the patient  
          with a state-developed fact sheet that explains the use of  
          the drug, appropriate methods for its use, need for medical  
          follow-up with their personal physician and other relevant  
          patient information.

          The California Nurses Association (CNA) states that the  
          provisions of this bill remove the barriers to access of EC  
          drugs.  CNA supports increasing availability to EC drug  
          therapy and has always been an advocate for ensuring access  
          to these types of contraception drugs.

           ARGUMENTS IN OPPOSITION  :    The California Catholic  
          Conference argues that because EC is currently available at  
          pharmacies without a prior physical examination of the  
          requesting patient, or prescription from a physician, it  
          would seem that a minimum standard of care should be to  
          require the dispensing pharmacists to complete appropriate  
          training concerning dispensing EC drug therapy to insure  
          that the pharmacist is able to adequately consult patients  
          concerning emergency contraception.


           ASSEMBLY FLOOR  : 
          AYES:  Berg, Bermudez, Calderon, Canciamilla, Chan, Chavez,  
            Chu, Cohn, Corbett, Correa, Daucher, Diaz, Dutra,  
            Dymally, Frommer, Goldberg, Hancock, Jerome Horton,  
            Shirley Horton, Jackson, Kehoe, Koretz, Laird, Leno,  
            Levine, Lieber, Liu, Longville, Lowenthal, Montanez,  
            Mullin, Nakano, Nation, Negrete McLeod, Nunez, Oropeza,  







                                                                SB 545
                                                                Page  
          6

            Parra, Pavley, Reyes, Ridley-Thomas, Salinas, Simitian,  
            Steinberg, Vargas, Wiggins, Wolk, Yee, Wesson
          NOES:  Aghazarian, Bates, Benoit, Bogh, Campbell, Cogdill,  
            Cox, Dutton, Garcia, Harman, Haynes, Houston, Keene, La  
            Malfa, La Suer, Leslie, Maddox, Matthews, Maze, McCarthy,  
            Mountjoy, Nakanishi, Pacheco, Plescia, Runner, Samuelian,  
            Spitzer, Strickland, Wyland


          CP:cm  9/11/03   Senate Floor Analyses 

                         SUPPORT/OPPOSITION:  SEE ABOVE

                                ****  END  ****